231 related articles for article (PubMed ID: 21377044)
1. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses.
Hänsel A; Günther C; Ingwersen J; Starke J; Schmitz M; Bachmann M; Meurer M; Rieber EP; Schäkel K
J Allergy Clin Immunol; 2011 Mar; 127(3):787-94.e1-9. PubMed ID: 21377044
[TBL] [Abstract][Full Text] [Related]
2. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
[TBL] [Abstract][Full Text] [Related]
3. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
[TBL] [Abstract][Full Text] [Related]
4. Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation.
Günther C; Starke J; Zimmermann N; Schäkel K
Clin Exp Dermatol; 2012 Mar; 37(2):169-76. PubMed ID: 22188261
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis in humans is associated with down-regulation of galectins in dendritic cells.
de la Fuente H; Perez-Gala S; Bonay P; Cruz-Adalia A; Cibrian D; Sanchez-Cuellar S; Dauden E; Fresno M; García-Diez A; Sanchez-Madrid F
J Pathol; 2012 Oct; 228(2):193-203. PubMed ID: 22271227
[TBL] [Abstract][Full Text] [Related]
6. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
7. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
Hänsel A; Günther C; Baran W; Bidier M; Lorenz HM; Schmitz M; Bachmann M; Döbel T; Enk AH; Schäkel K
J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
[TBL] [Abstract][Full Text] [Related]
8. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
Günther C; Blau K; Förster U; Viehweg A; Wozel G; Schäkel K
Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
[TBL] [Abstract][Full Text] [Related]
9. Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses.
Gilles S; Jacoby D; Blume C; Mueller MJ; Jakob T; Behrendt H; Schaekel K; Traidl-Hoffmann C
Clin Exp Allergy; 2010 Feb; 40(2):269-78. PubMed ID: 20210806
[TBL] [Abstract][Full Text] [Related]
10. Myeloid but not plasmacytoid blood DCs possess Th1 polarizing and Th1/Th17 recruiting capacity in psoriasis.
Khasawneh A; Baráth S; Medgyesi B; Béke G; Dajnoki Z; Gáspár K; Jenei A; Pogácsás L; Pázmándi K; Gaál J; Bácsi A; Szegedi A; Kapitány A
Immunol Lett; 2017 Sep; 189():109-113. PubMed ID: 28414181
[TBL] [Abstract][Full Text] [Related]
11. The pruritogenic mediator endothelin-1 shifts the dendritic cell-T-cell response toward Th17/Th1 polarization.
Nakahara T; Kido-Nakahara M; Ohno F; Ulzii D; Chiba T; Tsuji G; Furue M
Allergy; 2018 Feb; 73(2):511-515. PubMed ID: 28960333
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses.
Stelzner K; Herbert D; Popkova Y; Lorz A; Schiller J; Gericke M; Klöting N; Blüher M; Franz S; Simon JC; Saalbach A
Eur J Immunol; 2016 Aug; 46(8):2043-53. PubMed ID: 27214608
[TBL] [Abstract][Full Text] [Related]
13. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.
Guttman-Yassky E; Lowes MA; Fuentes-Duculan J; Whynot J; Novitskaya I; Cardinale I; Haider A; Khatcherian A; Carucci JA; Bergman R; Krueger JG
J Allergy Clin Immunol; 2007 May; 119(5):1210-7. PubMed ID: 17472813
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.
Zaba LC; Fuentes-Duculan J; Eungdamrong NJ; Abello MV; Novitskaya I; Pierson KC; Gonzalez J; Krueger JG; Lowes MA
J Invest Dermatol; 2009 Jan; 129(1):79-88. PubMed ID: 18633443
[TBL] [Abstract][Full Text] [Related]
15. Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis.
Kanai Y; Satoh T; Igawa K; Yokozeki H
Acta Derm Venereol; 2012 Jul; 92(4):367-71. PubMed ID: 22294262
[TBL] [Abstract][Full Text] [Related]
16. Innate immunity in the pathogenesis of psoriasis.
Sweeney CM; Tobin AM; Kirby B
Arch Dermatol Res; 2011 Dec; 303(10):691-705. PubMed ID: 21863252
[TBL] [Abstract][Full Text] [Related]
17. Mutual antagonism of T cells causing psoriasis and atopic eczema.
Eyerich S; Onken AT; Weidinger S; Franke A; Nasorri F; Pennino D; Grosber M; Pfab F; Schmidt-Weber CB; Mempel M; Hein R; Ring J; Cavani A; Eyerich K
N Engl J Med; 2011 Jul; 365(3):231-8. PubMed ID: 21774711
[No Abstract] [Full Text] [Related]
18. Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions.
Baker BS; Laman JD; Powles A; van der Fits L; Voerman JS; Melief MJ; Fry L
J Pathol; 2006 Jun; 209(2):174-81. PubMed ID: 16493599
[TBL] [Abstract][Full Text] [Related]
19. [The immune response against microbial infections in the skin--weak in atopic dermatitis and strong in psoriasis].
Palatsi R; Hägg P
Duodecim; 2011; 127(2):127-34. PubMed ID: 21442863
[TBL] [Abstract][Full Text] [Related]
20. A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis.
Choe YB; Hwang YJ; Hahn HJ; Jung JW; Jung HJ; Lee YW; Ahn KJ; Youn JI
Br J Dermatol; 2012 Oct; 167(4):762-7. PubMed ID: 22564054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
